AIX-EN-PROVENCE, FRANCE--(Marketwired - Apr 18, 2017) - SuperSonic Imagine (EURONEXT PARIS: SSI) (FR0010526814), a company specializing in ultrasound medical imaging, announced today that it will showcase the clinical benefits of its real-time ShearWave™ Elastography (SWE™) technology for non-invasive assessment of patients with chronic liver disease at the International Liver Congress (ILC 2017) or EASL, April 19 - 23 in Amsterdam.

SuperSsonic Imagine's Aixplorer is the only ultrasound system available to deliver ShearWave Elastography in real-time in a large anatomic region of interest. SWE is a quick, non-invasive exam that provides color-coded maps and quantitative measurement of tissue stiffness. For the evaluation of patients with chronic liver disease, one exam with one acquisition can quantify the liver stiffness on an ultrasound image to help diagnosing and staging fibrosis, furthermore the B-Mode ratio (brightness ratio between liver and kidney) can accurately quantify the level of steatosis.

"Aixplorer is a comprehensive diagnostic imaging tool that is easy to use. We've used it since 2011 to detect chronic liver disease, measure liver stiffness, indicate the level of fibrosis, and quantify the brightness of the liver, a sign of steatosis. We recently expanded our use of CHC screening in patients with severe fibrosis using its high performance conventional ultrasound modes, including B-mode and color Doppler," said Professor Thierry Poynard, Director of the Anti-Fibrosis Record Center at Pitié Salpêtrière Hospital, Pierre et Marie Curie University in Paris, France.

Over 300 peer-reviewed articles have demonstrated the clinical benefits of SWE in a wide range of clinical applications and more than 100 articles have demonstrated the reliability and effectiveness of SWE specifically for the assessment chronic liver diseases, including hepatitis B, C and NAFLD. A retrospective multicenter trial on 13 sites in Europe and Asia which included 1134 patients1 with chronic hepatitis has just been published in Hepatology journal. The study demonstrates the remarkable diagnostic performance of SuperSonic Imagine's SWE for the non-invasive evaluation of the fibrosis, using liver biopsy as a reference and demonstrates that the diagnostic performance of SWE is better or equivalent than VCTE technology for the main etiologies of chronic liver disease.

SuperSonic Imagine will exhibit and host live demonstrations on models at booth #110 throughout the show, highlighting enhanced capabilities of Aixplorer. In addition, there will be a hands-on workshop Wednesday, April 19, 2pm - 5:50pm, "Introduction to the EASL-EFSUMB elastography workshop at ILC 2017," participants will have a hands-on opportunity to learn how to perform liver elastography and to ask the experts about how to best perform the examinations and obtain reliable results using Shear Wave Ultrasound Elastography to assess chronic liver disease. Contact MCI ilc.registration@mci-group.com to register and for additional information.

Ultrasound Homepage